Defensins: Natural anti-HIV peptides

被引:0
作者
Chang, TL [1 ]
Klotman, ME [1 ]
机构
[1] Dept Med, Div Infect Dis, New York, NY 10029 USA
关键词
defensins; HIV innate immunity;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mammalian defensins are small cationic antimicrobial peptides predominantly found in leukocytes and epithelial cells engaged in host defense. These peptides act as effector molecules in innate immunity as well as regulators in adaptive immunity. Increasing evidence indicates that defensins are effective inhibitors of HIV-1. While the level of defensins in HIV-1 infected individuals has not been determined, neutropenia and neutrophil dysfunction associated with HIV disease progression may result in altered a-defensin production. This review provides an overview of the structure and function of defensins, and focuses on the anti-HIV-1 activity of defensins and the mechanism of this activity. Although many questions remain, studying the complex function of defensins in innate immunity against HIV has implications for our further understanding of disease progression and for the development of novel approaches to prevention and therapy.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 92 条
[1]   The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations [J].
Agerberth, B ;
Charo, J ;
Werr, J ;
Olsson, B ;
Idali, F ;
Lindbom, L ;
Kiessling, R ;
Jörnvall, H ;
Wigzell, H ;
Gudmundsson, GH .
BLOOD, 2000, 96 (09) :3086-3093
[2]   INCREASED PHAGOCYTOSIS AND GENERATION OF REACTIVE OXYGEN PRODUCTS BY NEUTROPHILS AND MONOCYTES OF MEN WITH STAGE-1 HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BANDRES, JC ;
TRIAL, J ;
MUSHER, DM ;
ROSSEN, RD .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01) :75-83
[3]   Human α-defensin 1 (HNP-1) inhibits adenoviral infection in vitro [J].
Bastian, A ;
Schäfer, H .
REGULATORY PEPTIDES, 2001, 101 (1-3) :157-161
[4]   Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2 [J].
Biragyn, A ;
Ruffini, PA ;
Leifer, CA ;
Klyushnenkova, E ;
Shakhov, A ;
Chertov, O ;
Shirakawa, AK ;
Farber, JM ;
Segal, DM ;
Oppenheim, JJ ;
Kwak, LW .
SCIENCE, 2002, 298 (5595) :1025-1029
[5]   Antibacterial peptides: basic facts and emerging concepts [J].
Boman, HG .
JOURNAL OF INTERNAL MEDICINE, 2003, 254 (03) :197-215
[6]   A single-nucleotide polymorphism in the human beta-defensin 1 gene is associated with HIV-1 infection in Italian children [J].
Braida, L ;
Boniotto, M ;
Pontillo, A ;
Tovo, PA ;
Amoroso, A ;
Crovella, S .
AIDS, 2004, 18 (11) :1598-1600
[7]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[8]  
CHANG TL, 2004, KEYST S MOL MECH HIV
[9]   CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from α-defensin-1 HIV inhibition [J].
Chang, TLY ;
François, F ;
Mosoian, A ;
Klotman, ME .
JOURNAL OF VIROLOGY, 2003, 77 (12) :6777-6784
[10]   INHIBITION OF PROTEIN KINASE-C BY DEFENSINS, ANTIBIOTIC PEPTIDES FROM HUMAN-NEUTROPHILS [J].
CHARP, PA ;
RICE, WG ;
RAYNOR, RL ;
REIMUND, E ;
KINKADE, JM ;
GANZ, T ;
SELSTED, ME ;
LEHRER, RI ;
KUO, JF .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :951-956